Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 Apr 2016

Bartolome Aleksandar, Boskovic Srdjan, Paunovic Ivan, Bozic Vesna, Cvejic Dubravka

Abstract excerpt

Stomatin-like protein 2 (SLP-2), a member of the stomatin protein family, has emerged as a potential molecular hallmark of tumor progression in several human malignancies. The aim of this study was to analyze SLP-2 expression pattern in benign and malignant thyroid tumors (n = 210) and to examine its relationship with clinicopathological parameters and BRAFV600E mutation in thyroid cancer. SLP-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Adenoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Proteins

Share to Carcinoma, Papillary

Share to Lymphatic Metastasis

Share to Thyroid Cancer, Papillary

Share to Thyroid Carcinoma, Anaplastic

Share to Thyroid Gland

Source

Identifiers

PMID: 26750533
DOI: 10.1111/apm.12505

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.PMID 26750533Read ↗

Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.Semantic proximity Read ↗

Expression of Salt-Inducible Kinase 2 (SIK2) and its Correlation with Immune Cell Infiltration and Prognosis in Thyroid Papillary CarcinomaSemantic proximity Read ↗

High-Level SLP-2 Expression and HER-2/neu Protein Expression Are Associated With Decreased Breast Cancer Patient SurvivalSemantic proximity Read ↗

Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study.Semantic proximity Read ↗

Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV600E-Positive Papillary Thyroid Cancer.Semantic proximity Read ↗

Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.Semantic proximity Read ↗

Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.Semantic proximity Read ↗

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid CarcinomaSemantic proximity Read ↗

Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer.Semantic proximity Read ↗

Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cellsSemantic proximity Read ↗

Spry2 expression correlates with BRAF mutation in thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.